EngiChem Lifesciences (CEO Ki-Young Son) and its subsidiary Messena announced on the 22nd that they opened the 'AI Mobility & Bio Research Center' (AMBL) at the Korea National University of Transport on the 18th to lead research and development and commercialization in the fields of AI mobility, advanced materials, and biomaterials.
In November 2024, EngiChem Life Sciences and the Korea National University of Transportation signed a 'Business Agreement for Industry-Academic Cooperation and Bio-Industry Advancement' and established the 'AI Mobility & Bio Research Institute (AMBL)' to put this into practice. The Korea National University of Transportation, a cooperative partner, is the only comprehensive university specializing in transportation in Korea, established in 1905, and specializes in mobility, secondary batteries, and bio.
The newly opened 'AI Mobility & Bio Research Institute' will conduct research and development to promote global commercialization by combining the advanced material analysis technology and AI technology of the Korea National University of Transport based on the world's first commercialized graphene material, graphene battery material, PDRN (PolyDeoxyRiboNucleotide, a cell regeneration promoting substance), Centella, and other biomaterials promoted by Mecenat, a subsidiary of Enzychem Life Sciences.
The Chungju Campus of the National University of Transportation, where the 'AI Mobility & Bio Research Center' (AMBL) of Engichem Lifesciences is located, is located in a transportation hub just one hour away from Pangyo Station by KTX. Together with Engichem Lifesciences' Plants 1 and 2 in Jecheon, Chungcheongbuk-do, and the Pharmaceutical Research Institute, the Biopharm in Eumseong, Chungcheongbuk-do, and the research and production site in the Osong Biopolis district adjacent to Sejong City, it will form the 'Engichem Lifesciences Research and Development and Production Cluster'.
At the opening ceremony, Son Ki-young, CEO of Engichem Lifesciences, said, “Through the AI Mobility & Bio Research Institute, we will actively pursue ▲joint development and cooperation to expand the new drug pipeline ▲strengthening the pharmaceutical business, pharmaceutical development capabilities and competitiveness ▲cooperating on R&D and commercialization in the graphene and secondary battery sectors ▲securing excellent talent and strengthening the industry-academia cooperation network ▲contributing to the local community and enhancing the corporate image.”
In his congratulatory speech, President Seung-jo Yoon of Korea National University of Transport said, “The AI Mobility & Bio Research Institute will become a mecca for developing cutting-edge technologies with Korea National University of Transport’s excellent research team by grafting AI technology onto cutting-edge materials, including graphene. We will cooperate and advance in various fields, including new drug development, graphene, and secondary batteries.”
The opening ceremony was attended by President Seung-jo Yoon of Korea National University of Transport, Vice President for Academic Affairs Jeong-ui Hong, Director of the Rise Business Division Seong-yeong Park, and Director of the Industry-Academia-Research Foundation Cheol Moon, and key figures such as Standard Graphene CEO Jeong-hoon Lee, BioFDNC CEO Sang-hyun Mo, HanDok Research Institute Director Byeong-gon Moon, and Kyunghee University College of Oriental Medicine Professor Deok-gyun Ahn (former), as well as Engichem Life Sciences CEO Ki-young Son, Vice President In-soo Kang, and AI Mobility & Bio Research Institute Director Jeong-seok Kim were also present.
- See more related articles
You must be logged in to post a comment.